Aquinox Pharmaceuticals Sets New 12-Month Low After Earnings Miss (AQXP)
Shares of Aquinox Pharmaceuticals (NASDAQ:AQXP) reached a new 52-week low during trading on Tuesday following a weaker than expected earnings announcement, Stock Ratings News reports. The company traded as low as $7.32 and last traded at $7.42, with a volume of 10,086 shares traded. The stock had previously closed at $7.56.
The company reported ($0.51) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.27) by $0.24.
Separately, analysts at Jefferies Group cut their price target on shares of Aquinox Pharmaceuticals from $17.00 to $16.00 in a research note on Tuesday.
The stock’s 50-day moving average is $8.40 and its 200-day moving average is $9.77. The company’s market cap is $79.0 million.
Aquinox Pharmaceuticals, Inc is a clinical-stage pharmaceutical company discovering and developing drug candidates to treat inflammation and cancer.